Applications of AI & ML in Biomanufacturing of Cell and Gene Therapies
This workshop highlights how AI/ML technologies are beginning to be applied to biomanufacturing and bioengineering of cell and gene therapies (CGT). AI/ML have demonstrated their utility in biocomputing and biomedical research applications, and are poised to become central to design, scaling, and optimization of bioengineering processes such as CAR-T cells, iPSC, and biomolecule production. Invited speakers from academia and industry will speak of their experience in leveraging these new intelligent technologies.
Authors
- Karen Weisinger
- Tom Londo
- Eric Neumann (ORCID: https://orcid.org/0000-0002-8025-2552)
Institutions
- ET Enterprises (United Kingdom) (GB)
- Applied Technologies (United States) (US)
- Vista Scientific (United States) (US)
Publication Details
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1142/9789819824755_0063
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00